$1432.29
20.341.44%
Ult. Agg.: Nov 10, 7:59 PM
The average analyst price target for Eli Lilly is $1,376.75, 3.7% below the current price. Of 22 analysts, 21 rate it Buy and 1 Hold. Targets range from $830 to $1,700. The latest change came on Nov 9, 2026, when Jefferies raised its price target on Eli Lilly from $1,610 to $1,700 and kept a Buy rating.
Price Target Range — 9 Quarters
Analyst Consensus — 22 Analysts
Rating Trend — Last 9 Months